Task: Answer the MCQ question.
Query: Which drug exhibits a 15.399% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a CCN1C(=O)C(CC(=O)Nc2ccccc2)S/C1=N\c1ccccn1
b O=C(CSc1nnnn1-c1cccnc1)Nc1ccc(F)cc1F
c CC(=O)Nc1ccc(S(=O)(=O)NCCC(=O)N2CCc3ccccc32)cc1
Answer: b. O=C(CSc1nnnn1-c1cccnc1)Nc1ccc(F)cc1F
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=C(CSc1nnnn1-c1cccnc1)Nc1ccc(F)cc1F
O=C(CSc1nnnn1-c1cccnc1)Nc1ccc(F)cc1F
N-(2,4-difluorophenyl)-2-(1-pyridin-3-yltetrazol-5-yl)sulfanylacetamide